Datum: 6.7.2008
The new device which can detect minute numbers of tumour cells circulating in the blood of lung cancer patients may one day make monitoring the disease as simple as taking a blood test, reported journal Nature.
In 2004, the US Food and Drug Administration approved a test to allow doctors to count the number of circulating tumour cells as a way of monitoring whether breast, colorectal or prostate cancer patients are responding to therapy. But the test does not collect sufficient numbers of tumour cells, or in sufficient purity, to perform genetic tests on the samples.
Credit: Jonathan Ashton/Science Photo Library
The new, improved version of the test will now enable doctors to perform genetic tests on these spreading cancer cells — potentially allowing them to decide which drugs might be most effective in stopping any tumours that might arise from the cells.
Whole article: http://www.nature.com
BIOFORUM 2010
Lodz, Poland, May 19-21, 2010
Mendel lectures: How DNA recombination maintains genome integrity
Mendel museum, Brno, April 15, 2010
Mendel lectures: Germ cell specification in mice
Mendel museum, Brno, April 29, 2010
The Second International Conference on Biological and Environmental Sciences (2ICBES)
Mansoura and Luxor, Egypt, March 15-20, 2010
XGen Congress
San Diego, CA, United States, March 15-19, 2010
Drug Discovery Technology World Asia 2010
Singapore, March 16-19, 2010
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
© 2006 South Moravian Innovation Centre
Interesting biotechnology content:
Biotechnology - Biotechnology information directory
Biotechnology Books no. 14 - 14th page of aour database of biotechnology books
Nobel Prize for chemistry of life
Full color vision given to monkeys